Table 1 Recommended core assessment battery for BPD effectiveness research
From: Consistency and coherence in treatment outcome measures for borderline personality disorder
Domain | Measure | Relevant psychometric properties |
|---|---|---|
BPD Symptoms & Severity | Borderline Symptom Checklist [28] | Cronbach’s α = .97; 1 week test-retest reliability, |
r = .84; good divergent and convergent validity | ||
Psychiatric comorbidity | Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scale [29] | Chronbach’s α = .80-.92; test-retest reliability, |
r = .83-.84; sensitivity = .66-.89; specificity = .71-.94 | ||
Substance Misuse | World Health Organization Alcohol, Smoking, and Substance Involvement Screening Test [30] | Cronbach’s α = .89; sensitivity = .80-.97; specificity = .71-.96; good divergent and convergent validity |
Quality of Life | SF-12 [31] | Test-retest reliability, r = .76-.89; good divergent and convergent validity |
Daily Functioning | World Health Organization Disability Assessment Schedule 2.0 [32] | Cronbach’s α = .94-.96; test-retest reliability, ICC = .93-.96; good construct and concurrent validity |
Reduction in polypharmacy | % prescribed multiple antipsychotics | N/A; Note, however, this metric is in line with the Hospital-Based Inpatient Psychiatric Services Core Measures [33] |
Service Utilization | Days hospitalized | N/A |
Suicide related behaviors | Self-rated, electronic Columbia Suicide Severity Rating Scale [34,35] | Cronbach’s α = .73-94; Kappa: .79 – 1.00; acceptable sensitivity and specificity |